Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Mallinckrodt
Colorcon
McKinsey
Baxter

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

DDAVP Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Ddavp patents expire, and what generic alternatives are available?

Ddavp is a drug marketed by Ferring Pharms Inc and is included in three NDAs.

The generic ingredient in DDAVP is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Drug patent expirations by year for DDAVP
Drug Prices for DDAVP

See drug prices for DDAVP

Recent Litigation for DDAVP

Identify potential future generic entrants

District Court Litigation
Case NameDate
Ferring B v. v. Allergan Inc.2012-04-05
Ferring BV v. Teva Pharmaceuticals2004-07-20

See all DDAVP litigation

Synonyms for DDAVP
[deamino-Cys1,D-Arg8]vasopressin
[deamino-Cys1]AVP
[deamino1]AVP
1-(3-Mercaptopropanoic Acid)-8-d-arginine Vasopressin Monoacetate
1-(3-Mercaptopropanoic acid)-8-D-argininevasopressin monoacetate (salt), trihydrate
1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin diacetate
1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin monoacetate (salt) trihydrate
1-(7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-(1-((2-amino-2-o
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide acetate(1:1)
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-n5-(diaminomethylidene)ornithylglycinamide acetate(1:2)
1-Deamino-8-D-arginine-vasopressin diacetate
1-deamino,D-AVP
1-Desamino-8-arginine Vasopressin
1-Desamino-8-D-arginine vasopressin
62288-83-9
62357-86-2
6917-99-3
8-d-Arginine-1-(3-mercapto-propanoic Acid)vasopresin Monoacetate
A810770
A810919
A833738
AC1L1EDS
AC1L21V2
AC1L21V5
AC1L506T
AC1Q5JBY
AC1Q5SZE
AC1Q5T0K
Adiuretin
Adiuretin SD
AN-7545
BCP12604
BCP13206
BCP15458
BDBM85094
C06944
C46H64N14O12S2.C2H4O2.3H2O
C4H10.CH2O
CAS_62357-86-2
CHEMBL2138698
CHEMBL264448
CONCENTRAID
CS-0952
CS-1199
CTK8F9082
D00291
D02235
dAVP
DDAVP (NEEDS NO REFRIGERATION)
DDAVP (TN)
Deamino Arginine Vasopressin
Deamino-8-D-arginine, l-, vasopressin
deamino-vasopressin
Desamino-8-D-arginine vasopressin, l-
Desmopresina [INN-Spanish]
DESMOPRESSIN
Desmopressin (Acetate)
Desmopressin (INN)
Desmopressin [INN:BAN]
Desmopressin acetate
Desmopressin acetate (USAN)
Desmopressin acetate [USAN:JAN]
Desmopressin acetate hydrate
Desmopressin acetate hydrate (JAN)
DESMOPRESSIN ACETATE PRESERVATIVE FREE
Desmopressin acetate trihydrate
Desmopressin diacetate
Desmopressin Monoacetate, Trihydrate
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
Desmospray
desnopressin
EINECS 240-726-7
FT-0603106
FT-0624526
FT-0653786
GTPL2181
GTPL2182
HY-17370
HY-17370A
KW-8008
L001026
LS-161413
LS-173612
LS-187262
Minirin
Minirinmelt (TN)
NCGC00181133-01
NCGC00181133-02
Noctiva
NSC_64759
Octim
Octostim
Presinex
SCHEMBL1172203
SCHEMBL13575732
Stimate
Stimate (TN)
Stimate injection
VA10693
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, monoacetate (salt), trihydrate
Vasopressin, Deamino Arginine
xoethyl)amino)-5-((diaminomethylene)amino)-1-oxopentan-2-yl)pyrrolidine-2-carboxamide diacetate
Paragraph IV (Patent) Challenges for DDAVP
Tradename Dosage Ingredient NDA Submissiondate
DDAVP (NEEDS NO REFRIGERATION) SPRAY, METERED;NASAL desmopressin acetate 017922
DDAVP INJECTABLE;INJECTION desmopressin acetate 018938
DDAVP SOLUTION;NASAL desmopressin acetate 017922
DDAVP TABLET;ORAL desmopressin acetate 019955
DDAVP SPRAY, METERED;NASAL desmopressin acetate 017922

US Patents and Regulatory Information for DDAVP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-002 Apr 25, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DDAVP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995   Start Trial   Start Trial
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995   Start Trial   Start Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Boehringer Ingelheim
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.